<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39337864</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>30</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2075-1729</ISSN><JournalIssue CitedMedium="Print"><Volume>14</Volume><Issue>9</Issue><PubDate><Year>2024</Year><Month>Aug</Month><Day>29</Day></PubDate></JournalIssue><Title>Life (Basel, Switzerland)</Title><ISOAbbreviation>Life (Basel)</ISOAbbreviation></Journal><ArticleTitle>Evaluation of Antimicrobial Resistance Patterns of <i>Pseudomonas aeruginosa</i> Strains Isolated among COVID-19 Patients in Brazil Typed by Fourier-Transform Infrared Spectroscopy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">1079</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/life14091079</ELocationID><Abstract><AbstractText>This study aimed to characterize <i>Pseudomonas aeruginosa</i> strains isolated from hospitalized patients during the COVID-19 pandemic. This was achieved using phenotypic and molecular techniques, including their antimicrobial resistance profile and biofilm formation. Eighteen strains were isolated from a hospital in Rio de Janeiro, Brazil, and identified by VITEK<sup>®</sup>2, MALDI-TOF/MS (VITEK MS<sup>®</sup> and MALDI Biotyper<sup>®</sup>), and 16S rRNA sequencing. Fourier-transform infrared (FTIR) spectroscopy, antimicrobial susceptibility testing, and biofilm formation and disinfectant tolerance tests were applied to evaluate the virulence characteristics of the strains. VITEK<sup>®</sup>2 (≥99%), VITEK MS<sup>®</sup> (≥82.7%), and MALDI Biotyper<sup>®</sup> (score ≥ 2.01) accurately identified the <i>P. aeruginosa</i> strains, but 16S rRNA sequencing did not differentiate the species <i>P. aeruginosa</i> from <i>P. paraeruginosa</i>. FTIR typing identified three different clusters, but no correlation between the phenotypical or antimicrobial susceptibility testing patterns was found. Most strains exhibited resistance to various antimicrobials. The exceptions were sensitivity to amikacin and norfloxacin, and consequently, these could be considered potential treatment options. Most strains (n = 15, 83.3%) produced biofilms on polystyrene. Sodium hypochlorite treatment (0.5%/15 min) was shown to be the most effective disinfectant for biofilm elimination. <i>P. aeruginosa</i> biofilm formation and tolerance to disinfectants demonstrate the need for effective cleaning protocols to eliminate contamination by this organism in the hospital environment and medical equipment.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>de Souza</LastName><ForeName>Paula Araujo</ForeName><Initials>PA</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology of Food and Sanitizes, INCQS/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Laboratory of Microbiological Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Santos</LastName><ForeName>Milena Cristina Silva Dos</ForeName><Initials>MCSD</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiological Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Miranda</LastName><ForeName>Rebeca Vitória da Silva Lage</ForeName><Initials>RVDSL</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiological Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Costa</LastName><ForeName>Luciana Veloso</ForeName><Initials>LV</Initials><Identifier Source="ORCID">0000-0003-1873-4056</Identifier><AffiliationInfo><Affiliation>Laboratory of Microbiological Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Raphael Paiva Paschoal</ForeName><Initials>RPP</Initials><AffiliationInfo><Affiliation>Hospital de Força Aérea do Galeão, Força Área Brasileira, Rio de Janeiro 21941-353, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>de Miranda</LastName><ForeName>Catia Aparecida Chaia</ForeName><Initials>CAC</Initials><Identifier Source="ORCID">0000-0002-8917-1249</Identifier><AffiliationInfo><Affiliation>Interdisciplinary Medical Research Laboratory, IOC/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>da Silva</LastName><ForeName>Ana Paula Roque</ForeName><Initials>APR</Initials><Identifier Source="ORCID">0000-0002-9076-0091</Identifier><AffiliationInfo><Affiliation>Analytical Indicators and Data Systems Section, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Forsythe</LastName><ForeName>Stephen James</ForeName><Initials>SJ</Initials><Identifier Source="ORCID">0000-0002-6709-0712</Identifier><AffiliationInfo><Affiliation>Foodmicrobe.com Ltd., Adams Hill, Keyworth, Nottingham NG12 5GY, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bôas</LastName><ForeName>Maria Helena Simões Villas</ForeName><Initials>MHSV</Initials><AffiliationInfo><Affiliation>Laboratory of Microbiology of Food and Sanitizes, INCQS/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandão</LastName><ForeName>Marcelo Luiz Lima</ForeName><Initials>MLL</Initials><Identifier Source="ORCID">0000-0003-1121-7312</Identifier><AffiliationInfo><Affiliation>Laboratory of Microbiological Control, Bio-Manguinhos/Fiocruz, Rio de Janeiro 21040-900, Brazil.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>CNPq/MCTI/FNDCT Nº 18/2021 - Faixa A - Grupos Emergentes Process n.º407747/2021-4</GrantID><Agency>National Council for Scientific and Technological Development</Agency><Country /></Grant><Grant><GrantID>Finance Code 001</GrantID><Agency>Coordenação de Aperfeicoamento de Pessoal de Nível Superior</Agency><Country /></Grant><Grant><GrantID>PROGRAMA E_13/2023 - AUXÍLIO BÁSICO À PESQUISA (APQ1) - 2023 - Ref. Proc. E-26/210.616/2024</GrantID><Agency>Fundação Carlos Chagas Filho de Amparo à Pesquisa do Estado do Rio de Janeiro</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>08</Month><Day>29</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Life (Basel)</MedlineTA><NlmUniqueID>101580444</NlmUniqueID><ISSNLinking>2075-1729</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">P. aeruginosa</Keyword><Keyword MajorTopicYN="N">multidrug-resistant</Keyword></KeywordList><CoiStatement>Author Prof SJ Forsythe was employed by the company Foodmicrobe.com Ltd. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as potential conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>7</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>8</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>8</Month><Day>16</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>22</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>9</Month><Day>28</Day><Hour>1</Hour><Minute>19</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>8</Month><Day>29</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39337864</ArticleId><ArticleId IdType="pmc">PMC11433527</ArticleId><ArticleId IdType="doi">10.3390/life14091079</ArticleId><ArticleId IdType="pii">life14091079</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Pulusu C.P., Manivannan B., Raman S.S., Singh S., Khamari B., Lama M., Peketi A.S.K., Datta C., Prasad K.N., Nagaraja V., et al. Localized outbreaks of Pseudomonas aeruginosa belonging to international high-risk clones in a south Indian hospital. J. Med. Microbiol. 2022;71:29–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">35286253</ArticleId></ArticleIdList></Reference><Reference><Citation>Albin O.R., Kaye K.S., McCreary E.K., Pogue J.M. Less Is More? Antibiotic Treatment Duration in Pseudomonas aeruginosa Ventilator-Associated Pneumonia. Clin. Infect. Dis. 2023;76:745–749.</Citation><ArticleIdList><ArticleId IdType="pubmed">36130230</ArticleId></ArticleIdList></Reference><Reference><Citation>EUCAST . European Committee on Antimicrobial Susceptibility Testing (EUCAST). Expected Resistant and Susceptible Phenotypes. EUCAST; Copenhagen, Denmark: 2021.</Citation></Reference><Reference><Citation>Pang Z., Raudonis R., Glick B.R., Lin T.J., Cheng Z. Antibiotic resistance in Pseudomonas aeruginosa: Mechanisms and alternative therapeutic strategies. Biotechnol. Adv. 2019;37:177–192.</Citation><ArticleIdList><ArticleId IdType="pubmed">30500353</ArticleId></ArticleIdList></Reference><Reference><Citation>Martak D., Valot B., Sauget M., Cholley P., Thouverez M., Bertrand X., Hocquet D. Fourier-Transform InfraRed Spectroscopy can quickly type Gram-negative bacilli responsible for hospital outbreaks. Front. Microbiol. 2019;10:1440.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6606786</ArticleId><ArticleId IdType="pubmed">31293559</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerrero-Lozano I., Galán-Sánchez F., Rodríguez-Iglesias M. Fourier transform infrared spectroscopy as a new tool for surveillance in local stewardship antimicrobial program: A retrospective study in a nosocomial Acinetobacter baumannii outbreak. Braz. J. Microbiol. 2022;53:1349–1353.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9433509</ArticleId><ArticleId IdType="pubmed">35644906</ArticleId></ArticleIdList></Reference><Reference><Citation>Muchaamba F., Stephan F. A Comprehensive Methodology for Microbial Strain Typing Using Fourier-Transform Infrared Spectroscopy. Methods Protoc. 2024;7:48. doi: 10.3390/mps7030048.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/mps7030048</ArticleId><ArticleId IdType="pmc">PMC11207048</ArticleId><ArticleId IdType="pubmed">38921827</ArticleId></ArticleIdList></Reference><Reference><Citation>Oho M., Nagasawa Z., Funashima Y., Ueda O., Watamabe S., Cui L., Miyamoto H., Sueoka E. Correlation of Strain Classification with IR Biotyper and Molecular Epidemiological Method of Pseudomonas aeruginosa. J. Assoc. Rapid Method Autom. Microbiol. 2021;31:29–40.</Citation><ArticleIdList><ArticleId IdType="pubmed">34986645</ArticleId></ArticleIdList></Reference><Reference><Citation>Lansbury L., Lim B., Baskaran V., Lim W.S. Co-infections in people with COVID-19: A systematic review and meta-analysis. J. Infect. 2020;81:266–275.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7255350</ArticleId><ArticleId IdType="pubmed">32473235</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X.J., Ge Y., Wu T., Zhao K., Chen Y., Wu B., Zhu F., Zhu B., Cui L. Coinfection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7213959</ArticleId><ArticleId IdType="pubmed">32408156</ArticleId></ArticleIdList></Reference><Reference><Citation>Pericolini E., Colombari B., Ferretti G., Iseppi R., Ardizzoni A., Girardis M., Sala A., Peppoloni S., Blasi E. Real-time monitoring of Pseudomonas aeruginosa biofilm formation on endotracheal tubes in vitro. BMC Microbiol. 2018;18:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6092828</ArticleId><ArticleId IdType="pubmed">30107778</ArticleId></ArticleIdList></Reference><Reference><Citation>Gaspari R., Spinazzola G., Teofili L., Avolio A.W., Fiori B., Maresca G.M., Spanu T., Nicolotti N., De Pascale G., Antonelli M. Protective effect of SARS-CoV-2 preventive measures against ESKAPE and Escherichia coli infections. Eur. J. Clin. Investig. 2021;51:e13687-94.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8646464</ArticleId><ArticleId IdType="pubmed">34599600</ArticleId></ArticleIdList></Reference><Reference><Citation>Qu J., Cai Z., Liu Y., Duan X., Han S., Liu J., Zhu Y., Jiang Z., Zhang Y., Zhuo C., et al. Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted Pseudomonas aeruginosa chronic colonizer. Front. Cell. Infect. Microbiol. 2021;11:641920.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8010185</ArticleId><ArticleId IdType="pubmed">33816347</ArticleId></ArticleIdList></Reference><Reference><Citation>Yoon S.H., Ha S.-M., Kwon S., Lim J., Kim Y., Seo H., Chun J. Introducing EzBioCloud: A taxonomically united database of 16S rRNA gene sequences and whole-genome assemblies. Int. J. Syst. Evol. Microbiol. 2017;67:1613–1617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5563544</ArticleId><ArticleId IdType="pubmed">28005526</ArticleId></ArticleIdList></Reference><Reference><Citation>Tamura K. MEGA11: Molecular Evolutionary Genetics Analysis Version 11. Mol. Biol. Evol. 2021;38:3022–3027.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8233496</ArticleId><ArticleId IdType="pubmed">33892491</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical and Laboratory Standards Institute (CLSI) Performance Standards for Antimicrobial Susceptibility Testing. 30th ed. CLSI supplement M100; Wayne, PA, USA: 2020.</Citation></Reference><Reference><Citation>Magiorakos A.P., Srinivasan A., Carey R.B., Carmeli Y., Falagas M.E., Giske C.G., Harbarth S., Hindler J.F., Kahlmeter G., Olsson-Liljequist B., et al. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: An international expert proposal for interim standard definitions for acquired resistance. Clin. Microbiol. Infect. 2012;18:268–281.</Citation><ArticleIdList><ArticleId IdType="pubmed">21793988</ArticleId></ArticleIdList></Reference><Reference><Citation>Vasconcellos L., Silva S.V., da Costa L.V., da Silva Lage de Miranda R.V., Reis C.M.F.D., da Silva Braga L.M.P., Silva C., Conceição G., Mattoso J., Silva I.B., et al. Phenotypical and molecular characterization of Acinetobacter spp. isolated from a pharmaceutical facility. Lett. Appl. Microbiol. 2023;76:101</Citation><ArticleIdList><ArticleId IdType="pubmed">37660241</ArticleId></ArticleIdList></Reference><Reference><Citation>Stepanović S., Vuković D., Hola V., Bonaventura G.D., Djukić S., Ćirković I., Ruzicka F. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by Staphylococci,” APMIS: Acta pathologica, microbiologica, et immunologica Scandinavica. APMIS. 2007;115:891–899.</Citation><ArticleIdList><ArticleId IdType="pubmed">17696944</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang Y.C., Sheng W.H., Li S.Y., Lin Y.C., Wang J.T., Chen Y.C., Chang S.C. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with Acinetobacter bacteremia. Clin. Infect. Dis. 2011;52:352–360.</Citation><ArticleIdList><ArticleId IdType="pubmed">21193494</ArticleId></ArticleIdList></Reference><Reference><Citation>Rudra B., Duncan L., Shah A.J., Shah H.N., Gupta R.S. Phylogenomic and comparative genomic studies robustly demarcate two distinct clades of Pseudomonas aeruginosa strains: Proposal to transfer the strains from an outlier clade to a novel species Pseudomonas paraeruginosa sp. nov. Int. J. Syst. Evol. Microbiol. 2022;72:11–24.</Citation><ArticleIdList><ArticleId IdType="pubmed">36355412</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsuchida S., Umemura H., Nakayama T. Current Status of Matrix-Assisted Laser Desorption/Ionization-Time-of-Flight Mass Spectrometry (MALDI-TOF MS) in Clinical Diagnostic Microbiology. Molecules. 2020;25:4775. doi: 10.3390/molecules25204775.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/molecules25204775</ArticleId><ArticleId IdType="pmc">PMC7587594</ArticleId><ArticleId IdType="pubmed">33080897</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulet X., Fernández-Esgueva M., Norte C., Zamorano L., del Barrio-Tofiño E., Oliver A., GEMARA-SEIMC-REIPI Pseudomonas study group Validation of MALDI-TOF for the early detection of the ST175 high-risk clone of Pseudomonas aeruginosa in clinical isolates belonging to a Spanish nationwide multicenter study. Enferm. Infecc. Microbiol. Clin. 2021;39:279–282.</Citation><ArticleIdList><ArticleId IdType="pubmed">34088448</ArticleId></ArticleIdList></Reference><Reference><Citation>Wamer C.N., Morse C.N., Gadient J.N., Dodson T.A., Carlson E.A., Prestwich E.G. Comparison of Small Biomolecule Ionization and Fragmentation in Pseudomonas aeruginosa Using Common MALDI Matrices. J. Am. Soc. Mass. Spectrom. 2023;34:355–365.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9983012</ArticleId><ArticleId IdType="pubmed">36696681</ArticleId></ArticleIdList></Reference><Reference><Citation>Souza P.A., Miranda R.V.S.L., Santos M.C.S., Costa L.V., Silva R.P.P.S., Miranda C.A.C., Bôas M.H.S., Brandão M.L.L. Evaluation of Fourier-Transform Infrared Spectroscopy as a rapid method to type Stenotrophomonas maltophilia strains isolated from pharmaceutical industry; Proceedings of the 8th International Symposium on Immunobiologicals; Rio de Janeiro, Brazil. 8–10 May 2024;  [(accessed on 15 August 2024)].  Available online:  https://www.arca.fiocruz.br/handle/icict/63778.</Citation></Reference><Reference><Citation>Ng Q.X., Ong N.Y., Lee DY X., Yau C.E., Lim Y.L., Kwa AL H., Tan B.H. Trends in Pseudomonas aeruginosa (P. aeruginosa) bacteremia during the COVID-19 pandemic: A systematic review. Antibiotics. 2023;12:409. doi: 10.3390/antibiotics12020409.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/antibiotics12020409</ArticleId><ArticleId IdType="pmc">PMC9952731</ArticleId><ArticleId IdType="pubmed">36830319</ArticleId></ArticleIdList></Reference><Reference><Citation>Idowu T., Ammeter D., Brizuela M., Jackson G., Alam S., Schweizer F. Overcoming β-Lactam resistance in Pseudomonas aeruginosa using non-canonical tobramycin-based antibiotic adjuvants. Bioorg. Med. Chem. Lett. 2020;30:127575.</Citation><ArticleIdList><ArticleId IdType="pubmed">32980511</ArticleId></ArticleIdList></Reference><Reference><Citation>WHO . WHO Bacterial Priority Pathogens List, 2024: Bacterial Pathogens of Public Health Importance to Guide Research, Development and Strategies to Prevent and Control Antimicrobial Resistance. WHO; Geneva, Switzerland: 2024.</Citation></Reference><Reference><Citation>Halat D.H. Moubareck CA, The Intriguing Carbapenemases of Pseudomonas aeruginosa: Current Status, Genetic Profile, and Global Epidemiology. Yale J. Biol. Med. 2022;95:507–515.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9765337</ArticleId><ArticleId IdType="pubmed">36568831</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizdal C.R. Molecular docking, and anti-biofilm activity of gold-complexed sulfonamides on Pseudomonas aeruginosa. Microb. Pathog. 2018;125:393–400.</Citation><ArticleIdList><ArticleId IdType="pubmed">30290269</ArticleId></ArticleIdList></Reference><Reference><Citation>Haghi F., Zeighami H., Monazami A., Toutouchi F., Nazaralian S., Naderi G. Diversity of virulence genes in multidrug resistant Pseudomonas aeruginosa isolated from burn wound infections. Microb. Pathog. 2018;115:251–256.</Citation><ArticleIdList><ArticleId IdType="pubmed">29273509</ArticleId></ArticleIdList></Reference><Reference><Citation>Shiralizadeh S., Keramat F., Hashemi S.H., Majzoobi M.M., Azimzadeh M., Alikhani M.S., Karami P., Rahimi Z. Investigation of antimicrobial resistance patterns and molecular typing of Pseudomonas aeruginosa isolates among Coronavirus disease-19 patients. BMC Microbiol. 2023;23:84.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10052215</ArticleId><ArticleId IdType="pubmed">36991311</ArticleId></ArticleIdList></Reference><Reference><Citation>Bassetti M., Vena A., Croxatto A., Righi E., Guery B. How to manage Pseudomonas aeruginosa infections. Drugs Cont. 2018;7:212527.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5978525</ArticleId><ArticleId IdType="pubmed">29872449</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel H., Gajjar D. Cell adhesion and twitching motility influence strong biofilm formation in Pseudomonas aeruginosa. Biofouling. 2022;38:235–249.</Citation><ArticleIdList><ArticleId IdType="pubmed">35345952</ArticleId></ArticleIdList></Reference><Reference><Citation>Karash S., Yahr T.L. Genome-Wide Identification of Pseudomonas aeruginosa Genes Important for Desiccation Tolerance on Inanimate Surfaces. mSystems. 2022;7:e0011422.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9239045</ArticleId><ArticleId IdType="pubmed">35469420</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>